Please try another search
Akoya Biosciences, Inc. is a life sciences technology company. The Company delivers spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology imager featuring rapid whole-slide multispectral scanning of up to seven colors with an 80-slide capacity. It offers a contract research services laboratory, which is called Advanced Biopharma Solutions (ABS).
Name | Age | Since | Title |
---|---|---|---|
Brian McKelligon | 53 | 2017 | President, CEO & Director |
Robert G. Shepler | 64 | 2015 | Chairman of the Board |
Thomas A. Raffin | 75 | 2015 | Director |
Matthew Winkler | 70 | 2017 | Independent Director |
Thomas Patrick Schnettler | 65 | 2019 | Independent Director |
Scott Edward Mendel | 55 | 2021 | Independent Director |
Myla P. Lai-Goldman | 64 | 2021 | Independent Director |
Padmanee Sharma | - | - | Member of Scientific Advisory Board |
James Patrick Allison | - | - | Member of Scientific Advisory Board |
Garry P. Nolan | 62 | 2015 | Chair of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review